Lansdale, PA, United States of America

Mark A Baxter

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Mark A Baxter in Pharmaceutical Manufacturing

Introduction

Mark A Baxter is an accomplished inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceutical manufacturing, particularly in the area of tablet homogeneity. His innovative approach has the potential to enhance the quality and consistency of pharmaceutical products.

Latest Patents

Mark A Baxter holds a patent for a "Method and system for determining the homogeneity of tablets." This invention presents a method and system for assessing the homogeneity of one or more components in a mixture of ingredients. It is especially useful for determining the homogeneity of a tabletted mixture of pharmaceuticals, which includes both active and inactive ingredients. The system monitors pharmaceutical material during tablet manufacture in various forms, such as powder mix, granular mix, and compressed tablets. Utilizing near-infrared (NIR) technology, the system analyzes the uniformity and mass balance of the pharmaceutical mixture, thereby controlling the tablet manufacturing process. A NIR spectral library is developed, encompassing pharmaceutical materials that span the normal process range. Uniformity assessment is achieved by comparing future production with this library of acceptable materials.

Career Highlights

Mark A Baxter is currently employed at Merck & Co., Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving manufacturing processes and ensuring product quality through advanced technologies.

Collaborations

Throughout his career, Mark has collaborated with notable colleagues, including Oksana M Tully and Samuel A Thornton. These partnerships have contributed to the advancement of pharmaceutical manufacturing techniques.

Conclusion

Mark A Baxter's contributions to the field of pharmaceutical manufacturing through his innovative patent demonstrate his commitment to enhancing product quality and consistency. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…